|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||38.93 - 39.62|
|52 Week Range||37.26 - 63.04|
|Beta (3Y Monthly)||0.48|
|PE Ratio (TTM)||10.59|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||45.15|
Does Mednax Inc. (NYSE:MD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use MEDNAX Inc's (NYSE:MD) P/E ratio Read More...
Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MEDNAX, Inc. (MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The MDR-AI Incubator brings together radiologists, a rich clinical dataset, and a select group of technology partners that will stimulate innovation and product development in radiology, improving radiologist’s accuracy and efficiency and overall quality of patient care. There are currently 15 active partners at various levels of engagement that are already delivering value through production use of existing models within the MEDNAX Radiology Common Imaging Platform.
Third paragraph, second sentence of release should read: In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Bethesda Health Urgent Care. MEDNAX, Inc. (MD), a leading physician services and health solutions provider, today announced the acquisition of Bethesda Radiology Associates, Inc., a private radiology physician group based in Boynton Beach, Fla. The practice will integrate with Radiology Associates of South Florida, LLC, a MEDNAX-affiliated physician practice located in Miami and serving all of South Florida.
One of the nation’s largest radiology practices, recognized as a leader in radiology, launches Artificial Intelligence Incubator and Radiology Centers of Excellence programs;
MEDNAX, Inc. (MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $492.5 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.
NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Moody's Investors Service ("Moody's") assigned a Ba2 rating to MEDNAX, Inc.'s $750 million of new unsecured notes. There is no change to the Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating, the Ba2 rating on the unsecured bonds due 2023, or SGL-1 Speculative Grade Liquidity Rating. Ratings assigned: MEDNAX, Inc.
MEDNAX, Inc. (MD), announced today that it is proposing to issue $750.0 million aggregate amount of senior notes due 2026 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). If the offering is successfully completed, MEDNAX intends to use the net proceeds from the offering to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S. The Notes will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
If you are currently a shareholder in MEDNAX Inc (NYSE:MD), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested. Read More...
Mednax (MD) delivered earnings and revenue surprises of -2.08% and -0.75%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Sunrise, Florida-based company said it had profit of 72 cents per share. Earnings, adjusted for amortization costs and stock option expense, were 94 cents per share. The results fell short of Wall ...
MEDNAX, Inc. (MD), today announced the acquisition of Associates in Diagnostic Radiology, P.C., a private radiology physician group based in Chattanooga, Tenn. The practice will integrate with Radiology Alliance, P.C., a MEDNAX-affiliated physician practice located in Nashville. This marks the Company’s eighth radiology services practice acquisition, further establishing MEDNAX Radiology Solutions as an industry leader, an innovator in health care informatics and a pioneer in telemedicine. Associates in Diagnostic Radiology was established in 1974.
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.